BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18318760)

  • 1. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
    Zhang MY; Fung TK; Chen FY; Chim CS
    J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.
    Fourouclas N; Li J; Gilby DC; Campbell PJ; Beer PA; Boyd EM; Goodeve AC; Bareford D; Harrison CN; Reilly JT; Green AR; Bench AJ
    Haematologica; 2008 Nov; 93(11):1635-44. PubMed ID: 18815196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia.
    Födermayr M; Zach O; Huber M; Machherndl-Spandl S; Wölfl S; Bösmüller HC; Hasenschwandtner S; Burgstaller S; Krieger O; Lutz D; Weltermann A; Hauser H
    Leuk Res; 2012 May; 36(5):588-90. PubMed ID: 22325365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of hypermethylation of SOCS gene in typical myeloproliferative disease].
    Qin W; Li LL; Lu HN; Huang BB; Xiu B; Bo LJ; Gao QM; Zhang WJ; Fu JF
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):772-6. PubMed ID: 22339915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
    Jost E; do O N; Dahl E; Maintz CE; Jousten P; Habets L; Wilop S; Herman JG; Osieka R; Galm O
    Leukemia; 2007 Mar; 21(3):505-10. PubMed ID: 17230231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
    Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM
    Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.
    Capello D; Gloghini A; Baldanzi G; Martini M; Deambrogi C; Lucioni M; Piranda D; Famà R; Graziani A; Spina M; Tirelli U; Paulli M; Larocca LM; Gaidano G; Carbone A; Sinigaglia F
    Hematol Oncol; 2013 Mar; 31(1):22-8. PubMed ID: 22488585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
    Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
    Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppressor of cytokine signalling-1 (SOCS-1) gene is overexpressed in Philadelphia chromosome negative chronic myeloproliferative disorders.
    Bock O; Hussein K; Brakensiek K; Buhr T; Schlué J; Wiese B; Kreipe H
    Leuk Res; 2007 Jun; 31(6):799-803. PubMed ID: 17030374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms.
    Fernández-Mercado M; Cebrián V; Euba B; García-Granero M; Calasanz MJ; Novo FJ; Vizmanos JL; García-Delgado M
    Leuk Res; 2008 Oct; 32(10):1638-40. PubMed ID: 18440067
    [No Abstract]   [Full Text] [Related]  

  • 14. Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.
    Cooper JC; Shi M; Chueh FY; Venkitachalam S; Yu CL
    Int J Oncol; 2010 May; 36(5):1201-8. PubMed ID: 20372794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
    Steensma DP; McClure RF; Karp JE; Tefferi A; Lasho TL; Powell HL; DeWald GW; Kaufmann SH
    Leukemia; 2006 Jun; 20(6):971-8. PubMed ID: 16598306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.
    Hookham MB; Elliott J; Suessmuth Y; Staerk J; Ward AC; Vainchenker W; Percy MJ; McMullin MF; Constantinescu SN; Johnston JA
    Blood; 2007 Jun; 109(11):4924-9. PubMed ID: 17317861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between socs3 mRNA expression and jak2v617f point mutation in bcr-abl negative patients with myelo-proliferative disease].
    Wang DM; Pan L; Zhang JM; Li YH; Wang HF; Wang XQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):479-83. PubMed ID: 18549612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.
    Zhou H; Miki R; Eeva M; Fike FM; Seligson D; Yang L; Yoshimura A; Teitell MA; Jamieson CA; Cacalano NA
    Clin Cancer Res; 2007 Apr; 13(8):2344-53. PubMed ID: 17438093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.
    Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM
    Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
    Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
    Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.